Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQGZ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,688
Award facts
- Contract value 100% obligated
- $6,688.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,688.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. This is a firm fixed-price delivery order with an ultimate completion date of February 26, 2026, issued without set-aside designation. The award was made on February 4, 2026, and fulfillment will occur at the vendor's Park Ridge facility.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 and awarded in November 2025, authorizes DLA to issue delivery orders for a comprehensive range of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to support the specialized pharmaceutical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQGZ3?
SPE2DR26FQGZ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FQGZ3 worth?
The government has obligated $6,688 on SPE2DR26FQGZ3.
Is contract SPE2DR26FQGZ3 an order under another contract?
Yes. SPE2DR26FQGZ3 is a delivery order under SPE2DR25D9156, an indefinite delivery contract.
Was contract SPE2DR26FQGZ3 competed?
The extent of competition for SPE2DR26FQGZ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award